icatibant
Showing 1 - 11 of 11
Icatibant in Pediatric Participants With Hereditary Angioedema
Not yet recruiting
- Hereditary Angioedema (HAE)
- Icatibant
- (no location specified)
Aug 19, 2022
SARS CoV 2 Infection Trial in Belfast (Icatibant, 0.9% Sodium Chloride Injection)
Recruiting
- SARS CoV 2 Infection
- Icatibant
- 0.9% Sodium Chloride Injection
-
Belfast, Antrim, United KingdomMater Infirmorum Hospital
Jun 6, 2022
Intradialytic Hypotension Trial (Icatibant, Placebo)
Not yet recruiting
- Intradialytic Hypotension
- Icatibant
- Placebo
- (no location specified)
Apr 17, 2023
Hereditary Angioedema Trial in Milano (Icatibant, Tranexamic Acid, Oral Placebo)
Completed
- Hereditary Angioedema
- Icatibant
- +3 more
-
Milano, ItalyUniversità degli Studi di Milano, Dipartimento di Medicina Inter
May 24, 2021
Hereditary Angioedema Trial in Worldwide (Icatibant, Placebo)
Completed
- Hereditary Angioedema
- Icatibant
- Placebo
-
Alabaster, Alabama
- +63 more
Jun 3, 2021
Hemodialysis-Induced Symptom, Mitochondrial Diseases Trial in Nashville (Icatibant, Placebo)
Completed
- Hemodialysis-Induced Symptom
- Mitochondrial Diseases
- Icatibant
- Placebo
-
Nashville, TennesseeVanderbilt University Medical Center
Oct 28, 2019
Heart Failure NYHA Class I, Heart Failure NYHA Class II, Heart Failure NYHA Class III Trial in Nashville (Valsartan 80 mg bid,
Withdrawn
- Heart Failure NYHA Class I
- +2 more
- Valsartan 80 mg bid
- +4 more
-
Nashville, TennesseeVanderbilt University Medical Center
Jan 9, 2018
ACE Inhibitor-associated Angioedema Trial in San Diego, Nashville (icatibant, Placebo)
Terminated
- ACE Inhibitor-associated Angioedema
- icatibant
- Placebo
-
San Diego, California
- +1 more
Dec 22, 2016